Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting
03. Oktober 2022 07:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the results...
Nuwellis, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
19. November 2021 16:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective November 17, 2021, the independent directors approved an equity award under Nuwellis’...
Nuwellis Selected as a Recipient of the Governor’s International Trade Award
19. Oktober 2021 08:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) was honored last week with the 2021 Governor's International Trade Award by Minnesota Governor Tim Walz. This...
Nuwellis, Inc. Announces Closing of $10.0 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option
17. September 2021 16:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today the closing of its previously announced underwritten public offering of 4,005,588...
Nuwellis, Inc. Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
14. September 2021 08:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective September 13, 2021, the independent directors approved an equity award under...
Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
24. August 2021 09:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective August 18, 2021, the independent directors approved four equity awards under...
Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01. Juli 2021 16:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., July 01, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective June 30, 2021, the Compensation Committee of the Board of Directors approved an...
Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
24. Juni 2021 08:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective June 22, 2021, the independent directors approved four equity awards under...
Nuwellis Announces New Appointments to Leadership Team
22. Juni 2021 08:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., June 22, 2021 (GLOBE NEWSWIRE) -- Continuing its dynamic growth in support of its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric...
Nationwide Access to Ultrafiltration Therapy Possible with Nuwellis and Premier, Inc. Collaboration
01. Juni 2021 08:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., June 01, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc., has been awarded a three-year national contract with Premier, Inc., effective...